ArticleEBioMedicine2025

Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults.

Ekaterina Vert-Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.